Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay it's onset.
 
The GameChanger
Several studies suggest a delay in onset of dementia with the recombinant shingles vaccine.
 
Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
The recombinant shingles vaccine is associated with lower risk of dementia

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe dementia's epidemiology and the significance of preventive interventions.
2. Discuss the strengths, weaknesses, and outcomes of the study.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-246-H01-P
Initial release date: 08/19/2024
Expiration date: 08/19/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings.
 
The GameChanger
Adopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management.
 
Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations

Previous GameChangers on PREVENT score

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.
2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-245-H01-P
Initial release date: 08/12/2024
Expiration date: 08/12/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The power of physical fitness in managing diabetes is transforming patient care. Join us this week as we discuss how pharmacists can significantly enhance patient outcomes by integrating exercise education into their practice, alongside traditional medication management.
 
The GameChanger
Incorporating brief but impactful conversations about the importance of physical fitness into patient consultations can significantly enhance diabetes management.
 
Guests
Mark Smith, Jr., PharmD, CDCES, AFAA-CGFI
Pharmacist
UAB Medicine

Ian Haywood, PharmD, BCPS, CDCES
Clinical Pharmacist
Baptist Memorial Hospital

 
Reference Materials
The Role of Exercise in Diabetes
Physical Activity and Diabetes Position from the ADA

Supplemental Continuing Education Courses
Glucose Whisperers: The Role of CGMs in Pharmacy Practice - 1hr
Guardians of the Glucose Galaxy: The Rise of CGMs - 1hr
Pharmacy and Continuous Glucose Monitoring: The Sweetest Pairing - 6.5hrs

Additional GameChangers Episodes
Continuous Glucose Monitors

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the impact of physical fitness on diabetes management.
2. Identify strategies for educating patients on exercise and diabetes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-224-H01-P
Initial release date: 08/05/2024
Expiration date: 08/05/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.
 
The GameChanger
Several new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad
 
References
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity


Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.
2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-238-H01-P
Initial release date: 07/29/2024
Expiration date: 07/29/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death.
 
The GameChanger
The study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer.
 
Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO, Seguridad

References
Multi-Vitamin Study
NIH Press Release

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of multivitamins.
2. Identify implications for healthy patients considering multivitamin use.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-226-H01-P
Initial release date: 07/22/2024
Expiration date: 07/22/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

While health inequity is considered by many to be the #1 issue in healthcare today, we’re still just learning to talk about it as part of pharmacy education. As preceptors, health equity and social determinants of health may not have been a language we learned as part of our education, and yet we rely on preceptors to help develop our learners in this area. What is our role in incorporating conversations and education around health equity and social determinants of health to better educate our learners in improving the lives of patients?
 
Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Sally Arif, PharmD, BCCP
Professor of Pharmacy Practice/Clinical Cardiology Pharmacist
Midwestern University College of Pharmacy
Rush Medical Center
Chicago, IL

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
 
Learning Objectives
At the end of this course, preceptors will be able to:
1. Discuss a preceptor's role in educating student pharmacists and pharmacy residents about social determinants of health
2. Describe strategies preceptors can use to incorporate social determinants of health into their teaching

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-210-H99-P
Initial release date: 7/17/2024
Expiration date: 7/17/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Follow CEimpact on Social Media:
LinkedIn
Instagram

In this week's episode, we dive into the fascinating world of gut health, including three actionable tips you can provide to patients. Explore the critical role of gut microbiome in health conditions ranging from autoimmune disorders to mental health to skin conditions.

The GameChanger
Health outcomes can be significantly impacted by addressing gut health issues through dietary modifications, understanding drug-nutrient depletions, and promoting the use of probiotics and prebiotics.
 
Guest
Anna Garrett, PharmD, BCPS
President, AnnaGarrett.com
 
Reference
How Gut Health Affects Your Whole Body

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the relationship between gut health and systemic conditions.
2. Identify strategies for assessing and addressing gut health issues, including dietary modifications, the use of probiotics and prebiotics, and the identification of drug-nutrient depletions.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-221-H01-P
Initial release date: 07/15/2024
Expiration date: 07/15/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

On this week's GameChangers episode, we discuss prevention of recurrent UTIs, including whether use of d-mannose or antibiotics are effective.
 
The GameChanger
Recurrent urinary tract infections plague some women throughout their lives. There are ways to prevent recurrent UTIs, however a recent study determined that d-mannose is not effective. We discuss what is effective.
 
Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women
A Randomized Clinical Trial

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe non-pharmacologic strategies proven to decrease recurrent UTIs.
2. Discuss selection of an antibiotic and a selected patient for continuous prophylaxis.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-220-H01-P
Initial release date: 07/08/2024
Expiration date: 07/08/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

In this week's episode of GameChangers, we focus on how pharmacists can prevent weight-based dosing errors. 

Listen in to learn more about:

• Which body weights to use for which medication-based dosing
• The four different scales of weight
• “Normal” weights for kids
• The Rule of 5 for dosing pediatric patients
• What the formula is for switching from pediatric dosing to adult dosing
• The definition of “Patient first language”

 
The GameChanger
Too often, health care providers don't dose medications based on weight. The pharmacist should be ensuring doses are correct based on patient weight.
 
Guests

Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Stephanie Weightman, PharmD, BCPS, BCPPS, BCEMP
Clinical Pharmacy Manager
Perfecting Peds

Reference
Pediatric Weight is Crucial to Perfecting the Dose
Updated antimicrobial dosing recommendations for obese patients

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss strategies to verify weight-based dosing accuracy to improve patient safety and therapeutic outcomes.
2. Explain appropriate dosing adjustments for commonly prescribed antibiotics in pediatric patients and patients with obesity.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-208-H01-P
Initial release date: 06/24/2024
Expiration date: 06/24/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Today's episode is an absolute must-listen to. The FDA's decision to approve the drug, Mifepristone, has been escalated in a lawsuit to the U.S. Supreme Court. And, last week, in a unanimous 9-0 decision, the U.S. Supreme Court rejected the challenge to the drug's approval. Today on our podcast, we are answering what exactly is happening with the drug Mifepristone, the legal challenges associated with this medication, and how this U.S. Supreme Court ruling directly impacts pharmacists today.

Regardless of your position on this topic, knowing and understanding the history and why the mifepristone conversation is happening is critical.

By the time you finish listening, you'll be inspired to take immediate action to join your local and state-level pharmacy association.

For more resources, including links to the discussions, education, and training mentioned in the episode, click here to learn more.

 
The GameChanger
Pharmacists should understand legal boundaries and ethical considerations surrounding medications like mifepristone to provide safe, compliant, and patient-centered care.
 
Guest
David Brushwood, RPh, JD
Senior Lecturer
University of Wyoming
 
Reference
Supreme Court Document on Ruling
Supreme Court preserves access to abortion pill

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the historical context and legal evolution of mifepristone regulation by the FDA, including key changes and their implications for pharmacy practice.

2. Identify the ethical responsibilities and state and federal legal requirements when dispensing medications such as mifepristone.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-209-H03-P
Initial release date: 06/24/2024
Expiration date: 06/24/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram